Prof. Dr. Yoon-Koo Kang

__Prof. Yoon-Koo Kang__ is a medical oncologist and Advisory Professor of the Department of Oncology at Asan Medical Center, University of Ulsan College of Medicine in Seoul, South Korea. His clinical and research interests include gastric cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma, and he is one of the leading experts in gastrointestinal oncology in Korea, having conducted many pioneering international clinical trials. --- ### Professional Background - __Experience/Years of Work:__ 1989 to present - __Based In:__ Seoul, South Korea --- ### Innovations & Contributions Prof. Kang is internationally acclaimed for his contributions to the clinical development of novel anticancer therapies, with more than 900 peer-reviewed publications and more than 59,000 citations. - __PRODIGY Trial (JCO, 2021):__ Principal investigator of this Phase III trial that paved the way for neoadjuvant chemotherapy as a new standard for resectable advanced gastric cancer. - __GIST Guidelines:__ Panel Member for Korean clinical practice guidelines for GIST; major contributor to international GIST trial research. Clarivate Highly Cited Researcher: Cross-Field category, which is based on cross-disciplinary global research impact. - __Korean Society of Oncology:__ President, 2017–2018. Recipient of the __Asan Award (2023)__ for clinical medicine for work on gastric cancer and GIST treatment via clinical trials. - __AMC Clinical Research Center:__ Director since 2006, over investigator initiated international trials.